To bridge the cancer innovation gap by facilitating equitable access to cutting-edge diagnostics, treatments, and technologies—including artificial intelligence, interventional oncology, medical device innovations, and advanced therapeutics—across Africa, while collaborating with African Union, governments, health economists, academia, and industry to shape enabling policies, build economic evidence, and drive sustainable adoption of these innovations for the benefit of African cancer patients.
Establish Africa as an active participant in the global cancer innovation ecosystem through strategic focus on artificial intelligence, interventional oncology, advanced therapeutics, and policy ecosystem development. We will identify priority innovations, develop context-appropriate access pathways, generate health economics evidence for decision-makers, forge multi-stakeholder partnerships with governments, African Union, industry, and academia, advocate for innovation-enabling policies, and build sustainable capacity for adoption of novel therapies, AI-driven diagnostics, and minimally invasive treatments across resource-varied settings.
We are actively seeking partners for this project.
Other AORTIC SIGs active in related fields: AORTIC’s Advocacy, Clinical Trials and Pathology SIGs work in areas that intersect with innovation access and implementation. This SIG will coordinate with them on cross-cutting initiatives.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
